CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KELLER, F.
Right arrow Articles by JOYCE, T. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KELLER, F.
Right arrow Articles by JOYCE, T. H., III

Canadian Journal of Anesthesia, Vol 31, 80-82, Copyright © 1984 by Canadian Anesthesiologists' Society

Clinical Reports: Uterine Rupture Associated with the Use of Vaginal Prostaglandin E2 Suppositories

FRANK KELLER MD1 and THOMAS H. JOYCE III MD1

1 Department of Anesthesiology, Baylor College of Medicine, Houston, Texas

Address correspondence to: Frank Keller, MD, Department of Anesthesiology, Jefferson Davis Hospital, 1801 Allen Parkway, Houston, Texas 77019.

The authors present an obstetrical case of silent uterine rupture due to prostaglandin E2 vaginal suppositories. Although this complication has been reported in the obstetrical literature, lack of attention to it in the anaesthesia literature, causes us to call this problem to the attention of anaesthetists.

Key Words: DRUG: prostaglandin E2 • COMPLICATION: uterine rupture • SURGERY: hysterectomy






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the Canadian Anesthesiologists' Society.